{"disease":{"id":"hidradenitis-suppurativa-hs","name":"hidradenitis suppurativa hs"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07021495","title":"SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)","phase":"","overall_status":"RECRUITING","enrollment_count":840,"lead_sponsor_name":"Leiden University Medical Center","has_results":false},{"nct_id":"NCT05620836","title":"A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":619,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT06212999","title":"A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":617,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT05620823","title":"A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":608,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT06855498","title":"Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":600,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT03173144","title":"Chronic Inflammatory Disease, Lifestyle and Treatment Response","phase":"","overall_status":"COMPLETED","enrollment_count":233,"lead_sponsor_name":"University of Southern Denmark","has_results":false},{"nct_id":"NCT07046039","title":"The Impact of Untreated Depression and Anxiety Among Patients With Skin Diseases in Jeddah, Saudi Arabia.","phase":"","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"King Abdulaziz University","has_results":false},{"nct_id":"NCT07287644","title":"A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Bluefin Biomedicine, Inc.","has_results":false},{"nct_id":"NCT02808975","title":"Safety and Efficacy of Adalimumab (Humira) for Hidradenitis Suppurativa (HS) Peri-Surgically","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":206,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT03487276","title":"Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":179,"lead_sponsor_name":"InflaRx GmbH","has_results":true},{"nct_id":"NCT02896920","title":"Canadian Humira Post Marketing Observational Epidemiological Study : Assessing Humira Real-life Effectiveness and Impact on HS Burden of Illness","phase":"","overall_status":"COMPLETED","enrollment_count":165,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT06926192","title":"Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Peking Union Medical College","has_results":false},{"nct_id":"NCT06785779","title":"Short-term Treatment Satisfaction in Hidradenitis Suppurativa Patients Initiated on Cosentyx in Routine Clinical Practice in Saudi Arabia","phase":"","overall_status":"RECRUITING","enrollment_count":77,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04430855","title":"A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease Symptoms","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT07244510","title":"Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":60,"lead_sponsor_name":"Sinocelltech Ltd.","has_results":false},{"nct_id":"NCT07109765","title":"Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Peking Union Medical College","has_results":false},{"nct_id":"NCT03894956","title":"Observational Study Evaluating Long-Term Safety and Effectiveness of Humira in Patients With Hidradenitis Suppurativa","phase":"","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT07388446","title":"MAIT Cells in Hidradenitis Suppurativa","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":45,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT07213973","title":"Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Incyte Corporation","has_results":false},{"nct_id":"NCT06241573","title":"A Study to Test Long-term Treatment With Spesolimab in People With a Skin Condition Disease Called Hidradenitis Suppurativa (HS) Who Took Part in a Previous Study With Spesolimab","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":39,"lead_sponsor_name":"Boehringer Ingelheim","has_results":false},{"nct_id":"NCT07489573","title":"Study of Efficacy and Safety of Secukinumab in Chinese Adult Patients With Moderate to Severe Hidradenitis Suppurativa","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":36,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07155239","title":"1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Wynn Medical Center","has_results":false},{"nct_id":"NCT07261072","title":"Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Peking Union Medical College","has_results":false},{"nct_id":"NCT07278011","title":"Molecular Evaluation of TAAR1 and JAK/STAT Pathway in Hidradenitis Suppurativa","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Trakya University","has_results":false},{"nct_id":"NCT03001115","title":"Post-Marketing Surveillance of Adalimumab in Korean Hidradenitis Suppurativa Subjects","phase":"","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"AbbVie","has_results":false},{"nct_id":"NCT07428915","title":"Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists","phase":"","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"AI Labs Group S.L","has_results":false},{"nct_id":"NCT06932003","title":"A Study to Explore the Safety, Tolerability, Efficacy, and Pharmacokinetics of LT-002-158 Tablets in Chinese Adult Patients With Hidradenitis Suppurativa","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"Leadingtac Pharmaceutical (Shaoxing) Co., Ltd.","has_results":false},{"nct_id":"NCT07414550","title":"Radiotherapy for Refractory Hidradenitis Suppurativa","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":10,"lead_sponsor_name":"Thomas Jefferson University","has_results":false},{"nct_id":"NCT07428941","title":"Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.","phase":"","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"AI Labs Group S.L","has_results":false},{"nct_id":"NCT04354012","title":"Hidradenitis Suppurativa Wound Care","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT05583604","title":"Managed Access Programs for AIN457, Secukinumab","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}